Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy
The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic strategies. Prostate tumors specifically express the prostate-specific membrane antigen (PSMA), a membrane-bound protease. As PSMA is highly overexpressed on malignant prostate tumor cells and as its expression r...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Medicinal research reviews
Year: 2018, Jahrgang: 39, Heft: 1, Pages: 40-69 |
| ISSN: | 1098-1128 |
| DOI: | 10.1002/med.21508 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/med.21508 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/med.21508 
|
| Verfasserangaben: | Till Wüstemann, Uwe Haberkorn, John Babich, Walter Mier |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694325601 | ||
| 003 | DE-627 | ||
| 005 | 20230427094955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200409r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/med.21508 |2 doi | |
| 035 | |a (DE-627)1694325601 | ||
| 035 | |a (DE-599)KXP1694325601 | ||
| 035 | |a (OCoLC)1341233609 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wüstemann, Till |d 1992- |e VerfasserIn |0 (DE-588)1190385597 |0 (DE-627)1669085279 |4 aut | |
| 245 | 1 | 0 | |a Targeting prostate cancer |b Prostate-specific membrane antigen based diagnosis and therapy |c Till Wüstemann, Uwe Haberkorn, John Babich, Walter Mier |
| 264 | 1 | |c 2019 | |
| 300 | |a 30 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 17 May 2018 | ||
| 500 | |a Gesehen am 09.04.2020 | ||
| 520 | |a The high incidence rates of prostate cancer (PCa) raise demand for improved therapeutic strategies. Prostate tumors specifically express the prostate-specific membrane antigen (PSMA), a membrane-bound protease. As PSMA is highly overexpressed on malignant prostate tumor cells and as its expression rate correlates with the aggressiveness of the disease, this tumor-associated biomarker provides the possibility to develop new strategies for diagnostics and therapy of PCa. Major advances have been made in PSMA targeting, ranging from immunotherapeutic approaches to therapeutic small molecules. This review elaborates the diversity of PSMA targeting agents while focusing on the radioactively labeled tracers for diagnosis and endoradiotherapy. A variety of radionuclides have been shown to either enable precise diagnosis or efficiently treat the tumor with minimal effects to nontargeted organs. Most small molecules with affinity for PSMA are based on either a phosphonate or a urea-based binding motif. Based on these pharmacophores, major effort has been made to identify modifications to achieve ideal pharmacokinetics while retaining the specific targeting of the PSMA binding pocket. Several tracers have now shown excellent clinical usability in particular for molecular imaging and therapy as proven by the efficiency of theranostic approaches in current studies. The archetypal expression profile of PSMA may be exploited for the treatment with alpha emitters to break radioresistance and thus to bring the power of systemic therapy to higher levels. | ||
| 534 | |c 2018 | ||
| 650 | 4 | |a prostate cancer | |
| 650 | 4 | |a prostate-specific membrane antigen | |
| 650 | 4 | |a PSMA | |
| 650 | 4 | |a review | |
| 650 | 4 | |a SAR | |
| 650 | 4 | |a tumor targeting | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Mier, Walter |d 1966- |e VerfasserIn |0 (DE-588)12029026X |0 (DE-627)69653567X |0 (DE-576)292141599 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicinal research reviews |d New York, NY : Wiley Interscience, 1981 |g 39(2019), 1, Seite 40-69 |h Online-Ressource |w (DE-627)320415384 |w (DE-600)2001841-1 |w (DE-576)114617503 |x 1098-1128 |7 nnas |a Targeting prostate cancer Prostate-specific membrane antigen based diagnosis and therapy |
| 773 | 1 | 8 | |g volume:39 |g year:2019 |g number:1 |g pages:40-69 |g extent:30 |a Targeting prostate cancer Prostate-specific membrane antigen based diagnosis and therapy |
| 856 | 4 | 0 | |u https://doi.org/10.1002/med.21508 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/med.21508 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200409 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 12029026X |a Mier, Walter |m 12029026X:Mier, Walter |d 910000 |d 911400 |e 910000PM12029026X |e 911400PM12029026X |k 0/910000/ |k 1/910000/911400/ |p 4 |y j | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 2 | ||
| 998 | |g 1190385597 |a Wüstemann, Till |m 1190385597:Wüstemann, Till |p 1 |x j | ||
| 999 | |a KXP-PPN1694325601 |e 3621135723 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Till Wüstemann, Uwe Haberkorn, John Babich, Walter Mier"]},"note":["First published: 17 May 2018","Gesehen am 09.04.2020"],"person":[{"given":"Till","display":"Wüstemann, Till","family":"Wüstemann","role":"aut"},{"role":"aut","family":"Haberkorn","display":"Haberkorn, Uwe","given":"Uwe"},{"family":"Mier","role":"aut","given":"Walter","display":"Mier, Walter"}],"recId":"1694325601","physDesc":[{"extent":"30 S."}],"id":{"doi":["10.1002/med.21508"],"eki":["1694325601"]},"title":[{"subtitle":"Prostate-specific membrane antigen based diagnosis and therapy","title":"Targeting prostate cancer","title_sort":"Targeting prostate cancer"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"relHost":[{"recId":"320415384","origin":[{"dateIssuedDisp":"1981-","publisher":"Wiley Interscience","publisherPlace":"New York, NY","dateIssuedKey":"1981"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"doi":["10.1002/(ISSN)1098-1128"],"zdb":["2001841-1"],"eki":["320415384"],"issn":["1098-1128"]},"title":[{"title":"Medicinal research reviews","title_sort":"Medicinal research reviews"}],"pubHistory":["1.1981 -"],"note":["Gesehen am 28.02.08"],"part":{"year":"2019","volume":"39","pages":"40-69","extent":"30","issue":"1","text":"39(2019), 1, Seite 40-69"},"language":["eng"],"disp":"Targeting prostate cancer Prostate-specific membrane antigen based diagnosis and therapyMedicinal research reviews","type":{"media":"Online-Ressource","bibl":"periodical"}}]} | ||
| SRT | |a WUESTEMANNTARGETINGP2019 | ||